Search Results for “”

A new study from Brakke consulting indicates that veterinarians are missing out on a big piece of the online sales pie.

Pet owners are spending more than ever before on their pets, and time-saving, specialty pet care services account for a significant portion of that spending.

Because what he costs is one thing. What he’s worth is quite another. And according to a new paper, he’s worth around $10,000.

A Singapore startup is testing its antiviral drug, RetroMAD1, against the SARS-CoV-2 beta-coronavirus that causes COVID-19. A spokesperson for Biovalence Technologies, the company that developed the drug, believes its drug could treat Covid-19. 

Veterinary clinics are resilient. They have already begun adapting to the added stress associated with COVID-19.

If you’re lucky enough to have a stash of N95 respirators, a new study from the National Institutes of Health (NIH) can help you extend their life, at least for a little while.

Do you have the bandwidth for another feline virus? How about two Because while SARS-CoV-2 is the new kid on the block, FeLV and  FIV haven’t gone anywhere.

Across the United States, dog parks have increased in number by 74% over the past 11 years (Trust for Public Land, 2019), and the number of pet dogs has increased by more than 20 million in the past two decades. Owning dogs can improve physical health and wellbeing. However, congregations of pets and people can increase the risk of contracting pathogens, including parasites.

Most veterinarians recommend year-round flea and tick prevention for dogs and cats due to the high prevalence of fleas and ticks and related complications, including flea allergy dermatitis, anemia, and vector-borne diseases such as Lyme, Babesiosis, and Bartonellosis that also pose a risk to pet owners.

Kössi and Lucky knew the people had COVID-19 before the people did. More remarkably, they knew before the people even began to show symptoms.